Your Health, We Care
Release date: 2024-08-15 17:11:29 Recommended: 122
Selpercatinib is a targeted therapy drug that is specifically used for cancers associated with the RET gene. It reduces the spread of cancer cells by inhibiting RET kinase. It is suitable for the treatment of lung cancer and thyroid cancer.
Production costs, regulatory standards, and pricing strategies in different countries and regions can lead to drug price differences.
Specification: 40mg*30 capsules
Price: about 2200 RMB/box
Specification: 40mg*120 capsules
Price: about 3375 RMB/box
The above prices are for reference only. Before starting the drug, the patient must be supervised by a physician who has experience in treating the disease. During the treatment, patients should strictly follow the doctor's instructions and go to the hospital regularly for evaluation and monitoring by the doctor; Patients should also have a comprehensive understanding of the indication range of the drug, the correct dosage and other information before taking the drug.
According to the drug instructions, the relevant contents of the indications are organized as follows:
Selpercatinib is indicated for the treatment of unresectable locally advanced or metastatic cholangiocarcinoma that has been treated. The drug is targeted at patients with fibroblast growth factor receptor 2 (FGFR2) fusions or other rearrangements detected by FDA-approved testing.
Selpercatinib is indicated for the treatment of adult patients with relapsed or refractory myeloid/lymphoid neoplasm (MLN) with fibroblast growth factor receptor 1 (FGFR1) rearrangement.
The recommended dosage of Selpercatinib is described below:
For the stable absorption and action of the drug, it is recommended to take Selpercatinib with meals at approximately the same time every day. When taking, the tablet should be swallowed whole, crushing, chewing, splitting, or dissolving the tablet may affect the release and absorption of the drug.
If a patient misses a dose of Selpercatinib and has 4 hours or more before the next dose, the missed dose can be taken as soon as possible; If the time is less than 4 hours, or if the patient vomits after taking the drug, the missed dose or the dose after vomiting should be skipped and the next dose should be continued at the scheduled time. Doing so reduces the risk of possible side effects and avoids ingesting too much of the drug in a short period of time.
[Warm tips] Patients should follow the doctor's medication guidance during the treatment period, and do not adjust the dosage of the drug or change the medication method without permission.
